Adaptilens chosen to participate in Harvard’s highly selective Launch Lab X GEO accelerator

Adaptilens was honored to participate in the prestigious 2021 Launch Lab X GEO program at Harvard Innovation Labs. This six-month virtual accelerator provided unparalleled access to world-class experts, founder talks, leadership circles, and pitch sessions, culminating in participation in the President’s Innovation Challenge. The program supported Adaptilens’ mission to develop groundbreaking intraocular lenses that restore clear vision at all distances without the need for glasses or contacts.

Learn more

Updates
  • November 15, 2024

    Adaptilens is excited to share Rowan Walrath's well-researched and insightful article in C&EN showcasing successful founder-led biotech companies like Adaptilens. We appreciate Rowan's recognition of Adaptilens's Founder and CEO Liane Clamen and Rowan's spotlight on champions of the founder-led movement like Chris Garabedian, Gianna Hoffman-Luca, and their team at Xontogeny and Perceptive Advisors, as well as Tony Kulesa and the Pillar VC team.

    Read More
  • November 12, 2024

    We’re excited to share that Adaptilens has been nominated for the Emerging MedTech Company of the Year at the 12th Annual #NEVYs24! Thank you to the New England Venture Capital Association (NEVCA) for this nomination. We are honored to be recognized with the other companies and breakthroughs of New England that are reshaping industries and driving the innovation economy forward. Read the full announcement here: https://lnkd.in/e548JKAk #NEVYsSurvivor #NEVCA #Innovation

  • October 19, 2024

    Adaptilens is pleased to announce that our CEO, Dr. Liane Clamen, was invited to participate in a panel discussion on the "Future of Anterior Innovation" at the Ophthalmology Innovation Summit next month.